A statistically significant (P < 0.0001) reduction in microvessel density (MVD) that was quantified using IHC CD31 staining was noted in BGJ398 treated PDXs compared to vehicle-treated tumours (Fig. 9a, b). Here, PECAM1 is linked to neoplasm.